UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 174

Sortiert nach

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1537-1538

2018

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1162-1169

2018

Link zum Volltext

Verfügbarkeit prüfen

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Link zum Volltext

Verfügbarkeit prüfen

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

Journal of hepatology, 2016, Vol.64 (2), p.S283-S283

2016

Link zum Volltext

Verfügbarkeit prüfen

The Albicc Model: A new Prognostic Tool for Prediction of Short-Term Survival in Patients with End-Stage Liver Disease

Journal of hepatology, 2016, Vol.64 (2), p.S284-S284

2016

Link zum Volltext

Verfügbarkeit prüfen

Bacterial infections in cirrhosis – a retrospective analysis updating on microbiology and resistance rates

Journal of hepatology, 2017, Vol.66 (1), p.S577-S577

2017

Link zum Volltext

Verfügbarkeit prüfen

P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-Ag

Journal of hepatology, 2014-04, Vol.60 (1), p.S244-S245

2014

Link zum Volltext

Verfügbarkeit prüfen

P1027 IS THE ELF-SCORE A VALID SUBSTITUTION FOR HVPG TO DETECT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) NON-INVASIVELY?

Journal of hepatology, 2014-04, Vol.60 (1), p.S417-S417

2014

Link zum Volltext

Verfügbarkeit prüfen

P0130 : VITRO-Score (vWF-Ag/thrombocytes) predicts mortality in patients with liver cirrhosis independent of child-pugh stage and meld score

Journal of hepatology, 2015-04, Vol.62, p.S349-S350

2015

Link zum Volltext

Verfügbarkeit prüfen

Liver Stiffness Assessed by Transient Elastography can not Predict the Hemodynamic Response to Non-Selective Betablockers

Journal of hepatology, 2016, Vol.64 (2), p.S287-S288

2016

Link zum Volltext

Verfügbarkeit prüfen

The novel point shear-wave elastography method ElastPQ® is accurate for non-invasive evaluation of liver fibrosis and portal hypertension

Journal of hepatology, 2017, Vol.66 (1), p.S674-S674

2017

Link zum Volltext

Verfügbarkeit prüfen

Preoperative von willebrand factor – antigen predicts clinical outcome after liver resection: a prospective, international, multicenter trial

Journal of hepatology, 2017, Vol.66 (1), p.S194-S194

2017

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

Journal of hepatology, 2017, Vol.66 (1), p.S373-S374

2017

Link zum Volltext

Verfügbarkeit prüfen

239 INFLUENCE OF BMI ON THE RESPONSE TO BETA-BLOCKER THERAPY IN PRIMARY AND SECONDARY PROPHYLAXIS OF VARICEAL BLEEDING IN LIVER CIRRHOSIS

Journal of hepatology, 2013-04, Vol.58, p.S103-S103

2013

Link zum Volltext

Verfügbarkeit prüfen

P1083 VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SEVERE ADVERSE EVENTS IN HCV PATIENTS WITH DAA BASED TRIPLE THERAPY

Journal of hepatology, 2014-04, Vol.60 (1), p.S438-S438

2014

Link zum Volltext

Verfügbarkeit prüfen

P0208 : Hemodynamic response to non-selective beta-blockers is not influenced by the presence of metabolic syndrome

Journal of hepatology, 2015-04, Vol.62, p.S383-S384

2015

Link zum Volltext

Verfügbarkeit prüfen

P0212 : Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

Journal of hepatology, 2015-04, Vol.62, p.S385-S385

2015

Link zum Volltext

Verfügbarkeit prüfen

P0218 : Factors associated with hemodynamic response to propranolol and carvedilol in cirrhotic patients

Journal of hepatology, 2015-04, Vol.62, p.S388-S388

2015

Link zum Volltext

Verfügbarkeit prüfen

O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Journal of hepatology, 2015-04, Vol.62, p.S216-S217

2015

Link zum Volltext

Verfügbarkeit prüfen

O019 : The value of different non-invasive tests for predicting the presence of clinically significant portal hypertension and esophageal varices in cirrhotic patients

Journal of hepatology, 2015-04, Vol.62, p.S200-S200

2015

Link zum Volltext

Verfügbarkeit prüfen

Interferon-Free Daa Regimens Decrease Portal Pressure and Halt Histological Necroinflammation in HIV/HCV coinfected Patients

Journal of hepatology, 2016, Vol.64 (2), p.S623-S623

2016

Link zum Volltext

Verfügbarkeit prüfen

The Evolution of Portal Pressure after Viral Suppression with Interferon-Free Therapies and its Correlation with the Change in Liver Stiffness

Journal of hepatology, 2016, Vol.64 (2), p.S138-S138

2016

Link zum Volltext

Verfügbarkeit prüfen

621 EVALUATION OF A NEW BALLOON OCCLUSION CATHETER DESIGNED FOR HVPG MEASUREMENT

Journal of hepatology, 2012-04, Vol.56, p.S246-S246

2012

Link zum Volltext

Verfügbarkeit prüfen

1410 A RANDOMIZED, CONTROLLED, MULTICENTRE TRIAL COMPARING ENDOSCOPIC BAND LIGATION VERSUS TIPS IN CIRRHOTIC PATIENTS WITH RECURRENT VARICEAL BLEEDING NON-RESPONDING TO PHARMACOLOGICAL THERAPY

Journal of hepatology, 2012-04, Vol.56, p.S555-S555

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 174

Suche als RSS-Feed

Aktive Filter

SpracheKoreanisch

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(173)

Publikationsform

Artikel
(174)

Sprache

Englisch
(171)
Japanisch
(5)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

The Albicc Model: A new Prognostic Tool for Prediction of Short-Term Survival in Patients with End-Stage Liver Disease

Bacterial infections in cirrhosis – a retrospective analysis updating on microbiology and resistance rates

P524 COMPARISON OF DIFFERENT MODELS IN PREDICTING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION INCLUDING ELF-SCORE AND vWF-Ag

P1027 IS THE ELF-SCORE A VALID SUBSTITUTION FOR HVPG TO DETECT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION (CSPH) NON-INVASIVELY?

P0130 : VITRO-Score (vWF-Ag/thrombocytes) predicts mortality in patients with liver cirrhosis independent of child-pugh stage and meld score

Liver Stiffness Assessed by Transient Elastography can not Predict the Hemodynamic Response to Non-Selective Betablockers

The novel point shear-wave elastography method ElastPQ® is accurate for non-invasive evaluation of liver fibrosis and portal hypertension

Preoperative von willebrand factor – antigen predicts clinical outcome after liver resection: a prospective, international, multicenter trial

Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severity

239 INFLUENCE OF BMI ON THE RESPONSE TO BETA-BLOCKER THERAPY IN PRIMARY AND SECONDARY PROPHYLAXIS OF VARICEAL BLEEDING IN LIVER CIRRHOSIS

P1083 VON WILLEBRAND FACTOR ANTIGEN (vWF-Ag): A NON-INVASIVE PREDICTOR OF TREATMENT RESPONSE AND SEVERE ADVERSE EVENTS IN HCV PATIENTS WITH DAA BASED TRIPLE THERAPY

P0208 : Hemodynamic response to non-selective beta-blockers is not influenced by the presence of metabolic syndrome

P0212 : Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

P0218 : Factors associated with hemodynamic response to propranolol and carvedilol in cirrhotic patients

O050 : A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

O019 : The value of different non-invasive tests for predicting the presence of clinically significant portal hypertension and esophageal varices in cirrhotic patients

Interferon-Free Daa Regimens Decrease Portal Pressure and Halt Histological Necroinflammation in HIV/HCV coinfected Patients

The Evolution of Portal Pressure after Viral Suppression with Interferon-Free Therapies and its Correlation with the Change in Liver Stiffness

621 EVALUATION OF A NEW BALLOON OCCLUSION CATHETER DESIGNED FOR HVPG MEASUREMENT

1410 A RANDOMIZED, CONTROLLED, MULTICENTRE TRIAL COMPARING ENDOSCOPIC BAND LIGATION VERSUS TIPS IN CIRRHOTIC PATIENTS WITH RECURRENT VARICEAL BLEEDING NON-RESPONDING TO PHARMACOLOGICAL THERAPY

Aktive Filter

Suchergebnisse filtern